The intestinal mucosa as a habitat of the gut microbiota and a rational target for probiotic functionality and safety

Microbial Ecology in Health and Disease

Volumn 16, Issue 2-3, 2004, Pages 137-144

  Derrien, Muriel ^a   Adawi, Diya ^b,c   Ahrné, Siv ^d   Jeppsson, Bengt ^b   Molin, Göran ^d   Osman, Nadia ^d   Štšepetova, Jelena ^a,e   Vaughan, Elaine E ^a   De Vos, Willem M ^a   Ouwehand, Arthur C ^f  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Probi AB   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF TARTU   (Estonia)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BIOSAFETY; COLITIS; COLONY FORMING UNIT; CONFERENCE PAPER; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; FECES MICROFLORA; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

ANIMALIA; BACTERIA (MICROORGANISMS); MICROBIOTA;

EID: 3342948690     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/08910600410032286     Document Type: Conference Paper

References (54)

1. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881-4.
2. McCracken VJ, Lorenz RG. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 2001; 3: 1-11.
3. Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998; 62: 1157-70.
4. Delie F, Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 1997; 14: 221-86.
5. Pontier C, Pachot J, Botham R, Lenfant B, Arnaud P. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. J Pharm Sci 2001; 10: 1608-19.
6. Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, Chiang HC, Hooper LV, Gordon JI. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003; 299: 2074-6.
7. Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A 1999; 96: 9833-8.
8. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003; 4: 269-73.
9. Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 2001; 73: 393S-8S.
10. Mogensen G, Salminen S, O'Brien J, Ouwehand A, Holzapfel W, Shortt C, Fondén R, Miller GD, Donohue D, Playne M, Crittenden R, Bianchi Salvadori B, Zink R. Inventory of microorganisms with a documented history of use in food. Bull IDF 2002; 377: 10-8.
11. Ahrendt GT, Barbul A. Nutrition and multiple organ dysfunction syndrome. Curr Opin Gastroenterol 1994; 10: 203-9.
12. Deitch EA. Nutrition and the gut mucosal barrier. Curr Opin Gen Surg 1993: 85-91.
13. Roos S, Jonsson H. A high-molecular-mass cell-surface protein from Lactobacillus reuteri 1063 adheres to mucus components. Microbiology 2002; 148: 433-42.
14. Ruseler-van Embden JGH, van Lieshout LMC, Gosselink MJ, Marteau P. Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins. Scand J Gastroenterol 1995; 30: 675-80.
15. Zhou JS, Gopal PK, Gill HS. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. Int J Food Microbiol 2001; 63: 81-90.
16. Pullan RD, Thomas GA, Rhodes M, Newcombe RG, Williams GT, Allen A, Rhodes J. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 1994; 35: 353-9.
17. Deplancke B, Hristova KR, Oakley HA, McCracken VJ, Aminov R, Mackie RI, Gaskins HR. Molecular ecological analysis of the succession and diversity of sulfate-reducing bacteria in the mouse gastrointestinal tract. Appl Environ Microbiol 2000; 66: 2166-74.
18. Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol (in press).
19. Zoetendal EG, Akkermans ADL, Akkermans van-Vliet WM, de Visser JAGM, de Vos WM. The host genotype affects the bacterial community in the human gastrointestinal tract. Microb Ecol Health Dis 2001; 13: 129-34.
20. Miller RS, Hoskins LC. Mucin degradation in human colon ecosystems. Fecal population densities of mucin-degrading bacteria estimated by a "Most probable number method". Gastroenterology 1981; 81: 759-65.
21. Salyers AA, West SE, Vercellotti JR, Wilkins TD. Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol 1977; 34: 529-33.
22. Strunk O, Ludwig W. ARB - a software environment for sequence data. Munich, Germany: Department of Microbiology, Technical University of Munich, 1995 (http://www.mikro.-biologie.tu-Muenchen.de/pub/ARB/documentation/arb.ps).
23. Hold GL, Pryde SE, Russell VJ, Furrie E, Flint HJ. Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 2002; 39: 33-9.
24. Salzman NH, de Jong H, Paterson Y, Harmsen HJ, Welling GW, Bos NA. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002; 148: 3651-60.
25. Zoetendal EG, Plugge CM, Akkermans ADL, de Vos WM. Victivallis vadensis gen. nov., sp. nov., a sugar-fermenting anaerobe from human faeces. Int J Syst Evol Microbiol 2003; 53: 211-5.
26. Wilson KH, Blitchington RB. Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 1996; 62: 2273-8.
27. Suau A, Bonnet R, Sutren M, Godon J-J, Gibson GR, Collins MD, Dore J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999; 65: 4799-807.
28. Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr 2001; 73: 465S-70S.
29. Sipsas NV, Zonios DI, Kordossis T. Safety of Lactobacillus strains used as probiotic agents. Clin Infect Dis 2002; 34: 1283-4.
30. Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, Sarna S, Valtonen V, Järvinen A. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002; 35: 1155-60.
31. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45: 223-8.
32. Harmsen HJM, Raangs GC, He T, Degener JE, Welling GJ. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 2002; 68: 2982-90.
33. Finlay BB, Falkow S. Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 1997; 61: 136-69.
34. Ouwehand AC, Saxelin M, Salminen S. Assessment of potential risk factors and related properties of clinical, faecal and dairy Bifidobacterium isolates. Biosci Microflora 23: 37-42.
35. Ouwehand AC, Tuomola EM, Lee YK, Salminen S. Microbial interactions to intestinal mucosal models. Methods Enzymol 2001; 337: 200-12.
36. Baumgartner A, Kueffer M, Simmen A, Grand M. Relatedness of Lactobacillus rhamnosus strains isolated from clinical specimens and such from food-stuffs, humans and technology. Lebensm Wiss Technol 1998; 31: 489-94.
37. Burns SM, Hull SI. Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5. Infect Immun 1998; 66: 4244-53.
38. Lilius E-M, Marnila P. Photon emission of phagocytes in relation to stress and disease. Experientia 1992; 48: 1082-91.
39. Rodriguez AV, Baigori MD, Alvarez S, Castro GR, Oliver G. Phosphatidylinositol-specific phospholipase C activity in Lactobacillus rhamnosus with capacity to translocate. FEMS Microbiol Lett 2001; 204: 33-8.
40. Chung K-T, Lu Z, Chou MW. Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria. Food Chem Toxicol 1998; 36: 1053-60.
41. Asahara T, Takahashi M, Nomoto K, Takayama H, Onoue M, Morotomi M, Tanaka R, Yokokura T, Yamashita N. Assessment of safety of Lactobacillus strains based on resistance to host innate defence mechanisms. Clin Diagn Lab Immunol 2003; 10: 169-73.
42. Mäkeläinen H, Tahvonen R, Salminen S, Ouwehand AC. In vivo safety assessment of two Bifidobacterium longum strains. Microbiol Immunol 2003; 47: 911-4.
43. Saadia R, Schein M, MacFarlane C, Boffard KD. Gut barrier function and the surgeon. Br J Surg 1990; 77: 487-92.
44. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 1992; 216: 117-34.
45. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract: the "undrained abscess" of multiple organ failure. Ann Surg 1993; 218: 111-9.
46. Freund HR. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition 1991; 7: 1-5.
47. van der Hulst RR, van Kreel BK, von Meyenfeldt MF, Brummer RJ, Arends JW, Deutz NE, Soeters PB. Glutamine and the preservation of gut integrity. Lancet 1993; 341: 1363-5.
48. Alverdy JC, Aoys E, Moss GS. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 1988; 104: 185-90.
49. Gonella PA, Helton WS, Robinson M, Wilmore DW. O-side chain of Escherichia coli endotoxin O11:4B is transported across the intestinal epithelium in the rat: evidence for increased transport during total parenteral nutrition. Eur J Cell Biol 1992; 59: 224-7.
50. Gardiner KR, Anderson NH, Rowlands BJ, Barbul A. Colitis and colonic mucosal barrier dysfunction. Gut 1995; 37: 530-5.
51. Gardiner KR, Erwin PJ, Anderson NH, Barr JG, Halliday MI, Rowlands BJ. Colonic bacteria and bacterial translocation in experimental colitis. Br J Surg 1993; 80: 512-6.
52. Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol 2001; Suppl 234: 29-40.
53. Helton WS. Nutritional issues in hepatobiliary surgery. Semin Liver Dis 1994; 14: 140-57.
54. Kasravi FB, Wang X, Guo W, Andersson R, Norgren L, Jeppsson B, Bengmark S. Reticuloendothelial system function in acute liver injury induced by D-galactosamine. J Hepatol 1995; 23: 727-33.